Evidence map›Paper›PMID 39390286›Full record

ArticleThe international journal of cardiovascular imaging2024

Predictors of hypercontractile heart phenotype in patients with chronic coronary syndromes or heart failure.

Yi Wang, Quirino Ciampi, Lauro Cortigiani, Angela Zagatina, Jaroslaw D Kasprzak, Karina Wierzbowska-Drabik, Maciej Haberka, Jorge Lowenstein, Rosina Arbucci, Diego M Lowenstein Haber and 27 more

Abstract read
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Yi WangDepartment of Cardiovascular Ultrasound and Non-Invasive Cardiology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Chengdu, China.
Quirino CiampiCardiology Division Fatebenefratelli Hospital of Benevento, Benevento, Italy. qciampi@gmail.com.
Lauro CortigianiCardiology Department, San Luca Hospital, Lucca, Italy.
Angela ZagatinaCardiology Department, Research Scientific Cardiocenter "Medika", St. Petersburg, Russian Federation.
Jaroslaw D KasprzakDepartment of Cadiology, Bieganski Hospital, Medical University, Lodz, Poland.
Karina Wierzbowska-DrabikDepartment of Internal Disease and Clinical Pharmacology, Medical University, Lodz, Poland.
Maciej HaberkaDepartment of Cardiology, SHS, Medical University of Silesia, Katowice, Poland.
Jorge LowensteinInvestigaciones Medicas, Buenos Aires, Argentina.
Rosina ArbucciInvestigaciones Medicas, Buenos Aires, Argentina.
Diego M Lowenstein HaberInvestigaciones Medicas, Buenos Aires, Argentina.
Sofia MarconiInvestigaciones Medicas, Buenos Aires, Argentina.
Pablo M MerloInvestigaciones Medicas, Buenos Aires, Argentina.
Patricia BarralCardiology Department, Ramos Mejia Hospital, Buenos Aires, Argentina.
Germán SoutoCardiology Department, Ramos Mejia Hospital, Buenos Aires, Argentina.
Ana Djordjevic-DikicCardiology Clinic, University Center Serbia, Medical School, University Clinical Center Serbia, University of Belgrade, Belgrade, Serbia.
Barbara ReisenhoferDepartment of Cardiology, Felice Lotti Hospital, Pontedera, Pisa, Italy.
Alla BoshchenkoCardiology Research Institute, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russian Federation.
Tamara RyabovaCardiology Research Institute, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russian Federation.
Hugo Rodriguez-ZanellaInstituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
Fausto RigoDepartment of Cardiology, Dolo Hospital, Venice, Italy.
Antonello D'AndreaDepartment of Cardiology, Umberto I Hospital, Nocera Inferiore (ASL Salerno), Siracusa, Italy.
Nicola GaibazziCardiology Department, Parma University Hospital, Parma, Italy.
Elisa MerliCardiology Unit, Ospedale Per Gli Infermi, Faenza, Italy.
Matteo LisiDepartment of Cardiovascular Disease-AUSL Romagna, Division of Cardiology, Ospedale S. Maria Delle Croci, Ravenna, Italy.
Iana SimovaCardiology Clinic, Heart and Brain Center of Excellence-University Hospital, Medical University Pleven, Pleven, Bulgaria.
Andrea BarbieriDivision of Cardiology, Department of Diagnostics, Clinical and Public Health Medicine, Policlinico University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy.
Doralisa MorroneCardiology Division, University of Pisa, Pisa, Italy.
Annalisa PitinoCNR, Institute of Clinical Physiology, Pisa-Roma-Reggio Calabria, Italy.
Michele De NesDepartment of Medicine and Health Science, Cardiology Institute Research Responsible University Hospital, University of Molise, Campobasso, Italy.
Giovanni L TripepiCNR, Institute of Clinical Physiology, Pisa-Roma-Reggio Calabria, Italy.
Lixue YinDepartment of Cardiovascular Ultrasound and Non-Invasive Cardiology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Chengdu, China.
Rodolfo CitroDepartment of Medicine and Health Science, Cardiology Institute Research Responsible University Hospital, University of Molise, Campobasso, Italy.
Scipione CarerjCardiology Division, University Hospital Polyclinic G. Martino, University of Messina, Messina, Italy.
Mauro PepiCentro Cardiologico Monzino, IRCCS, Milano, Italy.
Patricia A PellikkaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Eugenio PicanoCardiology Clinic, University Center Serbia, Medical School, University Clinical Center Serbia, University of Belgrade, Belgrade, Serbia.
Stress Echo 2030 study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypercontractile phenotype (HP) of the left ventricle (LV) is an actionable therapeutic target in patients with chronic coronary syndromes (CCS) or heart failure (HF), but its clinical recognition remains difficult. To assess the clinical variables associated with the HP. In a prospective, observational, multicenter study, we recruited 5122 patients (age 65 ± 11 years, 2974 males, 58%) with CCS and/or HF with preserved ejection fraction (EF). Systolic blood pressure (SBP) was measured. We assessed wall motion score index (WMSI), LV end-diastolic volume (EDV), end-systolic volume (ESV), EF, force (SBP/ESV), stroke volume (SV), arterial elastance (SBP/SV), and ventricular-arterial coupling (VAC, as SV/ESV). Univariable and multivariable logistic regression analysis assessed independent factors associated with the highest force sextile. For all the studied patients, force was 4.51 ± 2.11 mmHg/ml, with the highest sextile (Group 6) > 6.36 mmHg/ml. By multivariable logistic regression model, the highest sextile of force was associated with age > 65 years (OR 1.62, 95% CI 1.36-1.93, p < 0.001), hypertension (OR 1.76, 95% CI 1.40-2.21, p < 0.001), female sex (OR 4.52, 95% CI 3.77-5.42, p < 0.001), absence of beta-blocker therapy (OR 1.41, 95% CI 1.16-1.68), rest SBP ≥ 160 mmHg (OR 2.81, 95% CI 2.21-3.56, p < 0.001), high heart rate (OR 2.08, 95% CI 1.61-2.67, p < 0.001), and absence of prior myocardial infarction (OR 1.34, 95% CI 1.07-1.68, p = 0.012). Patients in the highest sextile of force showed lower values of WMSI, SV, EDV, and ESV, and higher values of arterial elastance and VAC. HP of the LV with high force was clinically associated with advanced age, female sex, high resting SBP, and the absence of β-blocker therapy. By transthoracic echocardiography, HP was associated with a small heart with reduced EDV, reduced SV despite high EF, and higher arterial elastance.

Indexed as

EchocardiographyHyperfunctionLeft ventriclePhenotypeSystolic function

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.